Topic summary

Tesamorelin has an approved indication — what that changes about the evidence

Compounds › Secretagogues & GH axis observational data tesamorelin GHRP class CJC-1295 ipamorelin

This is a generated summary. It shows the 5 most-liked posts from a topic of 28, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

p.mwangiTL217 Apr 2026#2

Picking up the opening post: that is the part I would want checked first.

Practical experience of tesamorelin, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.

23 likes 3mo

j.fonsecaTL28 May 2026#6

An observation about tesamorelin that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.

30 likes 3mo

ZieglerTL3Regular2 Jun 2026#12

I had written a reply contradicting post #11 and deleted it. Here is what survived.

A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes identity confirmation genuinely useful here.

22 likes 2mo

v.fontaineTL217 Jul 2026#25

I read post #23 twice before replying, because I had assumed the opposite.

What I would tell a new member reading about tesamorelin for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.

31 likes 11d

s.rasmussenTL227 Jul 2026 · edited#28

Acknowledging rather than arguing. The reasoning holds as far as I can follow it.

23 likes 1d

Read the full topic (28 posts)

This topic was referenced in

Reading a rodent study on a secretagogue without over-extrapolatingCompounds › Secretagogues & GH axis · 54 replies
Second pass at: Why this subcategory is stricter about sourcing than mostCompounds › Secretagogues & GH axis · 129 replies

Promoted into the documentation commons. The content of this topic is maintained at CJC-1295 — reference, with named maintainers and a review date. The promotion was discussed in doc review. Corrections are best raised against the document, which is the version that gets kept current.

Suggested topics

Topic	Participants	Replies	Views	Activity
Reading a rodent study on a secretagogue without over-extrapolating Compounds › Secretagogues & GH axis observational data GHRP class CJC-1295 needs a source Closed Posting this under the heading it deserves: Reading a rodent study on a secretagogue without over-extrapolating Everything below is what sits behind that. Reading a rodent study, and specifically the version…	+50	54	32k	10mo
Ipamorelin selectivity claims and where they came from — a second dataset Compounds › Secretagogues & GH axis CJC-1295 GHRP class tesamorelin ipamorelin Posting this under the heading it deserves: Ipamorelin selectivity claims and where they came from — a second dataset Everything below is what sits behind that. Posting a small dataset on Ipamorelin…		2	27k	14mo
Secretagogues and glucose tolerance: the mechanistic concern — what changed since Compounds › Secretagogues & GH axis GHRP class ipamorelin CJC-1295 observational data Wiki Closed Secretagogues and glucose tolerance: the mechanistic concern — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of…	+2	6	31k	2mo
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Compounds › Secretagogues & GH axis CJC-1295 observational data ipamorelin needs a source Solved On the subject in the title: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Working notes rather than a conclusion. Asking about GHRH analogues versus ghrelin mimetics…	+47	53	6.9k	2h
IGF-1 as a surrogate endpoint and its limitations — the long version Compounds › Secretagogues & GH axis CJC-1295 observational data ipamorelin needs a source Solved Closed On the subject in the title: IGF-1 as a surrogate endpoint and its limitations — the long version Working notes rather than a conclusion. A narrow question about IGF-1, deliberately narrow, because the broad…	+14	18	53k	12mo

Related topics — sharing the tags observational data, tesamorelin, GHRP class

Topic	Participants	Replies	Views	Activity
Publication patterns in the BPC-157 literature, examined Compounds › Repair & healing peptides preprint BPC-157 TB-500 needs a source Solved Posting this under the heading it deserves: Publication patterns in the BPC-157 literature, examined Everything below is what sits behind that. Putting the numbers in the first post, because a question about…	+40	45	3.4k	21h
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Data & Tools › Datasets data table confounding observational data Solved Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. An honest uncertainty about…	+14	18	3.4k	2mo
Coming back to: A community side-effect dataset, with its response rate and biases Data & Tools › Datasets observational data site feedback confounding data table On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Reading back through what has been written here about community…	+27	31	46k	9mo
CJC-1295 with and without DAC: what the modification does Compounds › Secretagogues & GH axis needs a source tesamorelin CJC-1295 GHRP class On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Putting the numbers in the first post, because a question about a compound…	+117	123	5.6k	22h
A critique that turned out to be unfair, retracted by its author Evidence › Study critique confounding risk of bias effect size observational data Wiki Posting this under the heading it deserves: A critique that turned out to be unfair, retracted by its author Everything below is what sits behind that. Critique, and specifically the version of it that the…	+34	38	20k	17h